Veracyte Inc logo

VCYT - Veracyte Inc News Story

$46.91 -8.5  -15.3%

Last Trade - 04/03/21

Sector
Healthcare
Size
Mid Cap
Market Cap £2.26bn
Enterprise Value £2.01bn
Revenue £84.6m
Position in Universe 1752nd / 6647

BRIEF-Veracyte and MAVIDx Announce Agreement to Develop High Volume COVID-19 Testing

Wed 29th July, 2020 1:48pm
July 29 (Reuters) - Veracyte Inc  VCYT.O :
    * VERACYTE AND MAVIDX ANNOUNCE AGREEMENT FOR MAVIDX TO
DEVELOP
ULTRA-HIGH VOLUME COVID-19 TESTING ON THE NCOUNTER SYSTEM
    * VERACYTE INC - APPROACH MAY ENABLE PROCESSING OF OVER
40,000
PATIENT SAMPLES PER DAY USING MOLECULAR BARCODES FOR VIRAL RNA
    * VERACYTE INC - FINANCIAL AND OTHER DETAILS WERE NOT
DISCLOSED.

Source text for Eikon:  ID:nBw8VRyWja 
Further company coverage:  VCYT.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.